SEC 13F Intelligence

OVASUSDTempest Therapeutics, Inc.

CUSIP 87978U108 · Yahoo Finance ↗ · Google Finance ↗

Tempest Therapeutics, Inc. (OVASUSD) has 1 institutional holders in Filings Flow’s 13F database, together reporting 269.8K shares worth $442,426 as of Q1 2026. The largest reported holders are Versant Venture Management, LLC, Osaic Holdings, Inc., and Royal Bank Of Canada.

Institutional Holders
1
Q1 2026
Reported Value
$442,426
Ticker
OVASUSD
Quarters Tracked
5

Ownership Trend

Institutional holders
Q2 ’21: 18Q2 ’21Q4 ’21: 14Q4 ’21Q4 ’22: 8Q4 ’22Q4 ’25: 1Q4 ’25Q1 ’26: 1Q1 ’26filingsflow.com
Total reported value
Q2 ’21: $13MQ2 ’21Q4 ’21: $7MQ4 ’21Q4 ’22: $2MQ4 ’22Q4 ’25: $774,246Q4 ’25Q1 ’26: $442,426Q1 ’26filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
Versant Venture Management, LLC$141M AUM0.31%$442,426269.8KQ1 2026
OSAIC HOLDINGS, INC.$68.3B AUM0.00%$21,33325.7KQ2 2025OLDER
ROYAL BANK OF CANADA$570.1B AUM$01Q3 2025OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.